当前位置:首页 - 行情中心 - 博瑞医药(688166) - 财务分析 - 资产负债表

博瑞医药

(688166)

  

流通市值:122.94亿  总市值:122.94亿
流通股本:4.22亿   总股本:4.22亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金968,854,789.05910,191,258.61,017,913,503.771,180,378,721.66
应收票据及应收账款342,304,985301,189,154.64310,840,465.48303,594,128.22
其中:应收票据3,146,253.41,270,00013,262,717.72778,519.2
应收账款339,158,731.6299,919,154.64297,577,747.76302,815,609.02
应收款项融资-26,241,563.252,773,4743,873,474
预付款项57,861,018.1454,327,505.645,973,085.3444,359,258.14
其他应收款合计18,177,062.2417,781,544.3414,765,437.5618,777,679.92
其中:应收利息---0
应收股利---0
存货344,738,500.51327,674,948.41316,997,999.76280,351,421.1
其他流动资产61,831,339.6252,675,676.252,858,042.3256,862,695.82
流动资产平衡项目0000
流动资产合计1,843,987,763.051,791,711,445.561,862,240,158.911,938,315,529.54
非流动资产:
长期股权投资49,598,937.0252,448,745.4233,923,648.4935,374,489.87
其他权益工具投资131,535,577.86132,805,192.72158,278,679.04125,278,679.04
其他非流动金融资产80,123,832.9880,342,220.745,488,275.7445,488,275.74
投资性房地产63,832,571.0564,561,623.25--
固定资产688,749,609700,666,030.24517,749,751.3402,232,556.86
在建工程1,671,071,567.41,556,133,743.151,738,427,874.11,666,256,600.42
使用权资产26,359,339.6529,200,149.6824,152,086.517,460,184.72
无形资产92,188,100.4183,003,465.2982,721,519.9381,640,001.65
商誉7,500,0007,500,0007,500,0007,500,000
长期待摊费用18,901,333.6321,410,980.1323,943,185.0426,872,275.17
递延所得税资产32,362,939.1227,776,872.0825,019,645.3323,936,101.81
其他非流动资产259,571,970.16266,500,984.82257,589,161.86300,917,554.02
非流动资产平衡项目0000
非流动资产合计3,121,795,778.283,022,350,007.482,914,793,827.342,722,956,719.3
资产平衡项目0000
资产总计4,965,783,541.334,814,061,453.044,777,033,986.254,661,272,248.84
流动负债:
短期借款149,844,570.55147,203,702.35164,345,678.38124,382,186.1
交易性金融负债5,197,2844,277,899547,437.5882,152
应付票据及应付账款239,349,839.89269,368,603.23259,056,669.66252,188,980.52
其中:应付票据31,500,00037,500,00040,061,695.5734,866,500
应付账款207,849,839.89231,868,603.23218,994,974.09217,322,480.52
合同负债16,044,606.1611,561,396.9718,837,836.8229,485,766.79
应付职工薪酬13,759,652.6813,271,917.5814,670,096.9641,430,093.66
应交税费20,066,937.3812,738,777.9312,657,896.6921,484,255.37
其他应付款合计17,060,311.27494,215.927,693,037.832,265,534.43
其中:应付利息0--0
应付股利0--0
一年内到期的非流动负债385,484,701.61356,791,886.18365,313,135.72315,203,650.13
其他流动负债12,080,395.6313,051,957.0316,289,731.6824,200,923.12
流动负债平衡项目0000
流动负债合计858,888,299.17828,760,356.19859,411,521.24811,523,542.12
非流动负债:
长期借款1,179,464,018.81,170,244,744.911,096,865,183.971,170,222,205.51
应付债券421,569,236.12417,013,063.2411,640,881.67405,830,127.8
租赁负债16,900,682.7319,143,264.4714,461,794.836,011,200.11
长期应付款38,720,00016,000,00026,000,00026,000,000
递延收益9,500,000.019,750,000--
非流动负债平衡项目0000
非流动负债合计1,666,153,937.661,632,151,072.581,548,967,860.471,608,063,533.42
负债平衡项目0000
负债合计2,525,042,236.832,460,911,428.772,408,379,381.712,419,587,075.54
所有者权益(或股东权益):
实收资本(或股本)422,465,363422,465,363422,465,078422,465,078
其他权益工具75,645,817.8575,645,817.8575,649,071.675,649,071.6
资本公积1,055,990,242.831,055,352,398.121,050,982,407.421,008,057,587.94
其他综合收益-63,207,612.7-61,937,997.84-57,882,513.17-57,882,513.17
盈余公积58,501,641.2558,501,641.2558,501,641.2558,501,641.25
未分配利润828,482,095.48746,131,722.28755,621,874.46684,852,404.01
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计2,377,877,547.712,296,158,944.662,305,337,559.562,191,643,269.63
少数股东权益62,863,756.7956,991,079.6163,317,044.9850,041,903.67
股东权益平衡项目0000
股东权益合计2,440,741,304.52,353,150,024.272,368,654,604.542,241,685,173.3
负债和股东权益合计4,965,783,541.334,814,061,453.044,777,033,986.254,661,272,248.84
公告日期2023-10-272023-08-252023-04-252023-04-25
审计意见(境内)标准无保留意见
TOP↑